Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28846745)

Published in PLoS One on August 28, 2017

Authors

Hiroki Masuda1, Shigeki Hirano1, Nobuyoshi Takahashi2, Etsuko Hatsugano3, Akiyuki Uzawa1, Tomohiko Uchida1, Ryohei Ohtani1, Satoshi Kuwabara1, Masahiro Mori1

Author Affiliations

1: Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
2: Department of Rehabilitation Sciences, Chiba Prefectural University of Health Sciences, Chiba, Japan.
3: School of Medicine, Chiba University, Chiba, Japan.

Articles by these authors

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2020) 3.93

Isolated transient myoclonus in the elderly: an under-recognized condition? Clin Neurol Neurosurg (2013) 2.04

First adult case of Helicobacter cinaedi meningitis. J Neurol Sci (2013) 0.91

Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes. Muscle Nerve (2015) 0.89

Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2014) 0.87

Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2015) 0.87

Guillain-Barré syndrome in Asia. J Neurol Neurosurg Psychiatry (2013) 0.84

Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Mult Scler (2015) 0.83

Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging (2015) 0.82

Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open (2015) 0.82

Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. J Neurol Sci (2015) 0.81

Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy? Case Rep Neurol (2014) 0.79

Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry (2014) 0.79

Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry (2015) 0.78

Serum high mobility group box 1 is upregulated in myasthenia gravis. J Neurol Neurosurg Psychiatry (2014) 0.78

Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study. J Neurol Sci (2015) 0.78

Incidental diagnosis of an asymptomatic adult-onset Alexander disease by brain magnetic resonance imaging for preoperative evaluation. J Neurol Sci (2015) 0.77

Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes. PLoS One (2014) 0.77

Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption. Mult Scler (2016) 0.76

Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited. J Neuroimmunol (2014) 0.76

Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2016) 0.76

Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry (2016) 0.76

A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells. Neurotherapeutics (2016) 0.75

Reply to letter to the Editor: isolated transient myoclonus in the elderly. Clin Neurol Neurosurg (2014) 0.75

Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.75

Corticosteroid-responsive leptomeningitis with IgG4-positive plasma-cell infiltration. J Neurol Sci (2015) 0.75

Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease. PLoS One (2015) 0.75

Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies. J Neurol Neurosurg Psychiatry (2015) 0.75

Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis? J Neurol Neurosurg Psychiatry (2014) 0.75

Benign neuromyelitis optica is rare in Japanese patients. Mult Scler (2014) 0.75

Clinical and magnetic resonance imaging features of elderly onset dentatorubral-pallidoluysian atrophy. J Neurol (2017) 0.75

Headache attributed to aeroplane travel and reversible cerebral vasoconstriction syndrome. Cephalalgia (2016) 0.75

Cryptococcosis mimicking lung cancer with brain metastasis. Clin Neurol Neurosurg (2015) 0.75

Pneumocephalus associated with Pott's puffy tumor. J Neurol Sci (2016) 0.75

A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J Neurol Neurosurg Psychiatry (2016) 0.75

Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis. J Neurol Sci (2015) 0.75

Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. J Neurol Sci (2016) 0.75

Recurrent, alternating orbital inflammation. J Neurol Sci (2015) 0.75

[Neurophysiologic assessment of disorders affecting the neuromuscular junction]. Brain Nerve (2011) 0.75

Muscle haematoma due to antithrombotic treatment for ischaemic stroke. J Clin Neurosci (2015) 0.75

Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies. J Neurol Neurosurg Psychiatry (2017) 0.75

Vogt-Koyanagi-Harada disease with meningitis-retention syndrome and increased CSF adenosine deaminase levels. Clin Neurol Neurosurg (2014) 0.75

A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain. Clin Neurol Neurosurg (2013) 0.75

Brain gray matter structural network in myotonic dystrophy type 1. PLoS One (2017) 0.75

Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation. J Neurol Sci (2017) 0.75

Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. J Neuroimmunol (2015) 0.75

Rapidly progressive Aspergillus meningitis successfully treated with voriconazole and corticosteroids. Neurol Sci (2017) 0.75

Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry (2017) 0.75

Transient global amnesia with a hippocampal lesion followed by transient epileptic amnesia. Seizure (2015) 0.75

Pain-related evoked potentials after intraepidermal electrical stimulation to Aδ and C fibers in patients with neuropathic pain. Neurosci Res (2017) 0.75

The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement. J Neuroimmunol (2019) 0.75

[Agnosia for streets and defective root finding]. Brain Nerve (2011) 0.75

Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity. J Neuroimmunol (2017) 0.75